Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|October 4, 2005
Imatinib induces hypothyroidism in patients receiving levothyroxineJan Willem B de Groot, Bernard A Zonnenberg, John T M Plukker, et al.Journal of Medical Economics|July 24, 2015
Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costsFrancis Vekeman, Matthew Magestro, Paul Karner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Dihydropyrimidinase deficiency and severe 5-fluorouracil toxicityAndré B P van Kuilenburg, Rutger Meinsma, Bernard A Zonnenberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Phase I dose-escalation study of the safety and pharmacokinetics of atrasentan: an endothelin receptor antagonist for refractory prostate cancerBernard A Zonnenberg, Gerard Groenewegen, Todd J Janus, et al.BJU International|September 16, 2010
Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trialNicholas D James, Armelle Caty, Heather Payne, et al.Physics in Medicine and Biology|June 27, 2013
Dosimetric feasibility of MRI-guided external beam radiotherapy of the kidneyMette K Stam, Marco van Vulpen, Maurits M Barendrecht, et al.Epilepsia Open|December 11, 2019
Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complexMenno Vergeer, Wendela L de Ranitz-Greven, Maureen P Neary, et al.Journal of Thoracic Imaging|October 6, 2010
Focal fatty areas in the myocardium of patients with tuberous sclerosis complex: a unique findingMiraude E A P M Adriaensen, Harm H H Feringa, Cornelia M Schaefer-Prokop, et al.British Journal of Clinical Pharmacology|November 19, 2015
Pharmacokinetics and pharmacodynamics of everolimus in patients with renal angiomyolipoma and tuberous sclerosis complex or lymphangioleiomyomatosisKlemens Budde, Bernard A Zonnenberg, Michael Frost, et al.Physics in Medicine and Biology|October 4, 2012
Navigators for motion detection during real-time MRI-guided radiotherapyMette K Stam, Sjoerd P M Crijns, Bernard A Zonnenberg, et al.Pageof 7